Search All

Articles

1. Strengthening the Reporting of Observational Studies in Epidemiology-Nutritional Epidemiology... 2016

   https://ncsu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbYLhA3iD-xjjECQvxcZE1iJ7bRNKkbnUBiP9qmiTsrdpK2okuqdZHgjofgAXg2noRzHKcQUcTERVPV_uKkOfY537GPTwh5TqGTBLyIfamjwmexpj6YBXBWZJSCfU4ksxn4fpvMIXG7F8YG7Rs92SqnF1vlZGxjK2cXpt_GifWPD_aYwCxScX-FrHDKWhfdeVkysBMrmHrMDyPO3X45ysO-E8_WDAyNzT0K6huzAYMNB0sqO6bJZvBf6OnV2bSaLyOhf8ZSdjKOWiu1f4fcdvTSGzR_4y65kZf3yM0Dt4B-n3zHVehyhCkPwGZ58O01FBx_VYV3pBeztNCMCzL0JqW3Pd4Z_nqZ7Jft_njnx9dvh20ufwAvQXivTs9OjnaHfllfvX7jDUpv-NlGzFclXgyv3gA8y3lxovIBOd8fnu29891LGnwD1Cy48kMGQpWGaiBW0hRBwUzCo0IyKAduKHWchuDUcJFSIJ8ZMFJqJM1CYE4x40bTNeJFmdBpnOaUs4yxIAO3PDDgyJgkj3PgID3it5JRsyYLh7JLcRy8l-bJKhSqckLtkV0U3wKLObRtQXU5Uq4nqSjThrNcg8YC0kiFkHkC90plgi-9yVmPPEHhq2ZD6kITqAHjElgrwHrkmUVgHo0SA3VGaT2fq_dH59cAnR5eB3TSAb10oKKCvmZSt4OiKnNM4tVBvuggR00K82XAjQ4QdIvpVK9hx2-f8VyFAih-IkUi4cx2MCyvfrqoxkYxlK_Mq9piRMKAGoJUHzZjZyGndiT2CO-Mqo4guzWgI2xSdKcT4J83469zytvJ-cDKfjqpcQE3kuwfwPoCk6xDj_5Li6N6pqBoVKs59CSgvbHokeES4BSAUyibWqSRsch0lqok44ViMdcq5UmhijDR1JjICLyzaEk7yKeUK_80wQ-2Z2eYRCyC9f9-Yo_ILXACEhv-yDfI6tVlnT8mq7iDaBP060duj7tw3D_-sGl17U83gdbn

   Lachat, Carl; Hawwash, Dana; Ocké, Marga C; Berg, Christina; Forsum, Elisabet...

   P Lo S Medicine, Vol. 13, Issue 6.

   Concerns have been raised about the quality of reporting in nutritional epidemiology. Research reporting guidelines such as the Strengthening the Reporting of Observational Studies in Epidemiology ... Read more

   Concerns have been raised about the quality of reporting in nutritional epidemiology. Research reporting guidelines such as the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement can improve quality of reporting in observational studies. Herein, we propose recommendations for reporting nutritional epidemiology and dietary assessment research by extending the STROBE statement into Strengthening the Reporting of Observational Studies in Epidemiology-Nutritional Epidemiology (STROBE-nut). Recommendations for the reporting of nutritional epidemiology and dietary assessment research were developed following a systematic and consultative process, coordinated by a multidisciplinary group of 21 experts. Consensus on reporting guidelines was reached through a three-round Delphi consultation process with 53 external experts. In total, 24 recommendations for nutritional epidemiology were added to the STROBE checklist. When used appropriately, reporting guidelines for nutritional epidemiology can contribute to improve reporting of observational studies with a focus on diet and health. Read less

   Journal Article  |  Full Text Online

2. Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on... 2016

   https://ncsu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Za9tAEF7aBEpfSpuWVr1QoW9CirWHDgiBJE5SAoaSOvRR7Eqr2uDaIZL-f2cPSasmDz1ehNm1LXlmPPd-g9BnAkIyS2sW5gLXIWWChGAWIFjJMQf7nORUI_C5yZy2PwvzYBf74X-zFtaAueqo7F-wd_hSWIDXwGS4Apvh-keMPh9nvOpq-fzbImTB_K77Edw0coDXnHihoGmdPmddyTUtGVplbDaRkyC4BGvWGjFQZ7va4CIa0jLclIuW3aZZrYP5sHHdmbzq9yi46sbC_eVuUzX9eM3rdaOr9KfBaeTmHmI396BVFI6TLEywHogO1sRdM5gtvY4140omsmQUpkEysqbXYG_eU-rjMIGRMqopj0U4NslRh823PzWfMXhWCo5uNHN9af_r4ozNdBj3GO3jNM9AO-6fLK7mY25OedFUD0EffqBtAusBqx56EIUrbe_qwvb2rs69-OX3NlzTgKv9muVz9MwGJP6JEawX6JHcHqAnC9ty8RJFR6tjV8SODlfH_q72tZj5Ssx8EDO_F7NX6ObifHn2JbRDNkJOkrQNpcwqJgQndUqYrASJBZhvAWqe84RnObiwuIa4kkNgz9NS8JrOSiKzugRtLiUmb5CPq0xwxiVJaUXprMrAKJQQh5aJZBJcSA8dADmKW4OfUmCaqokvHop78gxbBkQbQtIJjQtF40LR2EOfejoWoAdVcYtv5a5rijhNwGBSYJiHXhu6jje0bPFQOqH48AaFsT7d2a5XGmvdisrbf_7kO_R0_Oe8R3vtXSc_oD2l2j5aufsFWKeYMg

   Grant, Bridget F; Saha, Tulshi D; Ruan, W. June; Goldstein, Risë B...

   Jama Psychiatry (Chicago, Ill.), Vol. 73, Issue 1, pp. 1 - 9.

   IMPORTANCE: Current information on the prevalence and sociodemographic and clinical profiles of individuals in the general population with DSM-5 drug use disorder (DUD) is limited. Given the presen... Read more

   IMPORTANCE: Current information on the prevalence and sociodemographic and clinical profiles of individuals in the general population with DSM-5 drug use disorder (DUD) is limited. Given the present societal and economic context in the United States and the new diagnostic system, up-to-date national information is needed from a single uniform data source. OBJECTIVE: To present nationally representative findings on the prevalence, correlates, psychiatric comorbidity, disability, and treatment of DSM-5 DUD diagnoses overall and by severity level. DESIGN, SETTING, AND PARTICIPANTS: In-person interviews were conducted with 36 309 adults in the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions–III, a cross-sectional representative survey of the United States. The household response rate was 72%; person-level response rate, 84%; and overall response rate, 60.1%. Data were collected April 2012 through June 2013 and analyzed from February through March 2015. MAIN OUTCOMES AND MEASURES: Twelve-month and lifetime DUD, based on amphetamine, cannabis, club drug, cocaine, hallucinogen, heroin, nonheroin opioid, sedative/tranquilizer, and/or solvent/inhalant use disorders. RESULTS: Prevalences of 12-month and lifetime DUD were 3.9% and 9.9%, respectively. Drug use disorder was generally greater among men, white and Native American individuals, younger and previously or never married adults, those with lower education and income, and those residing in the West. Significant associations were found between 12-month and lifetime DUD and other substance use disorders. Significant associations were also found between any 12-month DUD and major depressive disorder (odds ratio [OR], 1.3; 95% CI, 1.09-1.64), dysthymia (OR, 1.5; 95% CI, 1.09-2.02), bipolar I (OR, 1.5; 95% CI, 1.06-2.05), posttraumatic stress disorder (OR, 1.6; 95% CI, 1.27-2.10), and antisocial (OR, 1.4; 95% CI, 1.11-1.75), borderline (OR, 1.8; 95% CI, 1.41-2.24), and schizotypal (OR, 1.5; 95% CI, 1.18-1.87) personality disorders. Similar associations were found for any lifetime DUD with the exception that lifetime DUD was also associated with generalized anxiety disorder (OR, 1.3; 95% CI, 1.06-1.49), panic disorder (OR, 1.3; 95% CI, 1.06-1.59), and social phobia (OR, 1.3; 95% CI, 1.09-1.64). Twelve-month DUD was associated with significant disability, increasing with DUD severity. Among respondents with 12-month and lifetime DUD, only 13.5% and 24.6% received treatment, respectively. CONCLUSIONS AND RELEVANCE: DSM-5 DUD is a common, highly comorbid, and disabling disorder that largely goes untreated in the United States. These findings indicate the need for additional studies to understand the broad relationships in more detail; estimate present-day economic costs of DUDs; investigate hypotheses regarding etiology, chronicity, and treatment use; and provide information to policy makers about allocation of resources for service delivery and research. Findings also indicate an urgent need to destigmatize DUD and educate the public, clinicians, and policy makers about its treatment to encourage affected individuals to obtain help. Read less

   Journal Article  |  Full Text Online

3. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel... 2019

   https://ncsu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA5OYfgi3vAuefBNqm2T3h433dDBwIf5PHpJtondxlbwf_iLPUmaNpuKii9lNGkZ_b6cnJNzQ-iKAEnsgHtWlLjcol5CLNgWwFiJ3Bj2Zz-isgKfeZjzrnNhvoxiv_03tHAPwBWpsn-At3op3IDfADJcAWa4_gpoWOGqMajMChHpHszqywYcTET6coA8V670e-WMWV63ZIehJ1VSVUTAFuPVme3ZG3ut50-mIJemuU7r0YUNdFLlKF4Wi5ko7rmoKzqNYZ8rVs7s26Jeoeo81ZuNa1b2mGrcPjBc_J0R04FnVQqOeUDhREawByuFKhVavEoWraRuYLKLmDI0UA2JPwl3dc7wcpOOhBfJUdVpVbEnA-d5LoEWHl7fdunPo2v1tvVQAzVAmAkF-7FbmfARjQLtG5dRgmv_ZRs19fOmnUJKfWWwi3ZKQwO3FGH20Aab7qNmvwylOEB5xRs843iNN9hkA9Y8wJI3WPMGC96szpS8qedPprjkzSF67nYGdw9W2XvDSkkYFlbic0LCzKehQ5Mo8e04SECbdbwwZgHlKQdDnYB2zmGJe3bqMM9JCKN-yDLRgSBzjxF2szCJvZiRgGaU2lkIe0UK5mnqM4-BZnmCjtQXGs5VZZWh_nan346coe2aY-doi8MqZhdoU4iKS4nVB5a6ZOI

   Burisch, Johan; Jess, Tine; Egeberg, Alexander

   Clinical Gastroenterology And Hepatology, Vol. 17, Issue 13, p. 2704.

   It is not clear whether the co-occurrence of immune-mediated inflammatory diseases (IMIDs) affects the course of inflammatory bowel diseases (IBD). We investigated the occurrence of IMIDs in relati... Read more

   It is not clear whether the co-occurrence of immune-mediated inflammatory diseases (IMIDs) affects the course of inflammatory bowel diseases (IBD). We investigated the occurrence of IMIDs in relation to onset of IBD and the effects of concurrent IMIDs on IBD outcomes in a nationwide study of the Danish population. We used a nationwide cohort of all individuals diagnosed with IBD, including Crohn's disease (CD) or ulcerative colitis (UC), in Denmark from 2007 through 2016 (n = 14,377). Patients were match with individuals without IBD from the general population (controls, n = 71,885). All cohort members were followed from birth until 2016, their migration, or their death. The occurrence of IMIDs was assessed using the Danish national patient register and Registry of Medicinal Products Statistics. A total of 3,235 patients with a diagnosis of IBD (22.5%) has also received a diagnosis of an IMID; most IMIDs occurred before the onset of IBD (n = 2,600, 80.3%). The most common IMIDs observed were psoriasis, asthma, type 1 diabetes, and iridocyclitis. Patients with IBD treated with infliximab were at reduced risk of developing IMIDs (CD adjusted odds ratio [aOR], 0.52; 95% CI, 0.34-0.81 and UC aOR, 0.47; 95% CI, 0.29-0.76). Co-occurrence of IMIDs increased the risk of surgery in patients with CD that developed IMIDs after CD onset (aOR, 2.30; 95% CI, 1.46-4.20) but not in UC. In a nationwide study of the Danish population, 22.5% of patients with IBD also had at least 1 concurrent IMID. Co-occurrence of IMIDs increased the risk of surgery in patients with CD. Read less

   Journal Article

See all 2,804,284 article results